Profit Taking is Legal: GOOGL & CRY Edition

I would think that I am not the only one who needs occasional reminders about best practices in portfolio management… like taking profits in non-core items for example. To that end, both GOOGL and CRY suffer the profit taker’s axe today. Ref. Friday’s post. CRY was around 20% on this most recent trade and I can’t remember what Google was. It was bought on the … Continue reading Profit Taking is Legal: GOOGL & CRY Edition

nftrh plus

NFTRH+’s Cryolife Post Unlocked (Public)

[edit] Arrrgh,they turned me into a day trader. Taking 9%. [edit2] I bought it back again on the pullback; we’ll see how it works out. First as usual with me, the disclaimers. I make bad trades and I highlight ideas that do not work out. I am human and therefore do not have guru status. Examples of failures were recent forays into Sugar (it actually … Continue reading NFTRH+’s Cryolife Post Unlocked (Public)

nftrh plus

NFTRH+; A Medical Device Co. to Support

Cryolife is a richly valued medical device company and your fundamental research would be required to understand its growth vs. valuation. NFTRH+ is only about charts. As you know, I’ve kept CRY on radar in the Charts & Notes segment periodically, using this weekly chart. Today it is getting hammered as it makes an acquisition (which can be reviewed at the link above). These types … Continue reading NFTRH+; A Medical Device Co. to Support

CRY Me No Tears

Since this is a spot on the internet that is not trying to harvest your eyeballs (no ads, man), misrepresent itself as a guru service or otherwise present uneven views of the writer’s strengths and faults, I feel the need to also present my screw ups and/or items currently not working, after putting up posts like the GILD profit-take. In that post I noted 2 … Continue reading CRY Me No Tears

nftrh plus

NFTRH+; Upcoming ‘Buy Op’ on a Medical Device Company

The company is CryoLife (CRY), a stock that provided some nice profits last year before turning bearish this year.  You can review the website if interested.  It is an innovative company with a valuation that indicates Wall Street’s former excitement.  As is typical, they piled in too late and too hard.  Now the fallout, as the company could not keep up with expectations. On the … Continue reading NFTRH+; Upcoming ‘Buy Op’ on a Medical Device Company

nftrh plus

CRY: An Old Fashioned Tout for NFTRH+ (plus extended brain dump)

First the disclaimer: You’ve got to have a good market for these things to work (unless of course you’re highlighting short setups).  When CRY was highlighted it was a decent market, even though Brexit and its embedded head fake were directly ahead.  NFTRH+ has had losers (DBA comes to mind), but far more winners. Gold bugs obsessed with the miners as if they are the … Continue reading CRY: An Old Fashioned Tout for NFTRH+ (plus extended brain dump)